LOS ANGELES, Jan. 17, 2014 (GLOBE NEWSWIRE) -- Glancy Binkow & Goldberg LLP announces that all purchasers of the securities of Quality Systems, Inc. ("QSI" or the "Company") (Nasdaq:QSII) between May 26, 2011 and July 25, 2012, inclusive (the "Class Period"), have until January 21, 2014, to file a motion to be appointed as lead plaintiff in the shareholder lawsuit filed in the United States District Court for the Central District of California.
A COPY OF THE COMPLAINT IS AVAILABLE FROM THE COURT OR FROM GLANCY BINKOW & GOLDBERG LLP. PLEASE CONTACT US AT (212) 682-5340, TOLL-FREE AT (888) 773-9224, OR AT SHAREHOLDERS@GLANCYLAW.COM TO DISCUSS THIS MATTER OR IF YOU PURCHASED SHARES BEFORE THE CLASS PERIOD. IF YOU INQUIRE BY EMAIL PLEASE INCLUDE YOUR MAILING ADDRESS, TELEPHONE NUMBER AND NUMBER OF SHARES PURCHASED.
QSI develops and markets healthcare information systems that automate medical and dental practices and networks of practices in the United States.The Complaint alleges that throughout the Class Period the Company and certain of its executive officers issued a series of material misstatements or failed to disclose material facts concerning QSI's financial prospects, including its financial guidance for fiscal years 2012 and 2013.
To be a member of the above-described Class, you need not take any action at this time or you may retain counsel of your choice. To learn more about this action or if you still hold shares of QSI purchased prior to May 26, 2011, and have any questions concerning this Notice or your rights or interests with respect to these matters, please contact Michael Goldberg, Esquire, of Glancy Binkow & Goldberg LLP, 1925 Century Park East, Suite 2100, Los Angeles, California 90067, Toll-Free at (888) 773-9224, or contact Gregory Linkh, Esquire, of Glancy Binkow & Goldberg LLP at 122 E. 42nd Street, Suite 2920, New York, New York 10168, at (212) 682-5340, by e-mail to shareholders@glancylaw.com, or visit our website at http://www.glancylaw.com.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.